AWS for Industries

Make the most of AWS re:Invent 2020 – Life Sciences Attendee Guide

AWS re:Invent routinely fills several Las Vegas venues with standing-room only crowds, but we are bringing it to you with an all-virtual and free event this year. This year’s conference is gearing up to be our biggest yet and we have an exciting program planned with five keynotes, 18 leadership sessions, and over 500 breakout sessions beginning November 30. Hear how AWS experts and inspiring members of the Life Sciences & Genomics industry are using cloud technology to transform their businesses and innovate on the behalf of their customers.

For Life Sciences attendees looking to get the most out of their experience, follow these steps:

  • Register for re:Invent.
  • Take a look at all of the Life Sciences sessions available, as well as lots of other information and additional activities, in our curated Life Sciences Attendee Guide!
  • Check back on this post regularly, as we’ll continually update it to reflect the newest information.

Life Sciences at re:Invent 2020

AWS enables pharma and biotech companies to transform every stage of the pharma value chain, with services that enhance data liquidity, operational excellence, and customer engagement. AWS is the trusted technology provider with the cost-effective compute and storage, machine learning capabilities, and customer-centric know how to help companies embrace innovation and bring differentiated therapeutics to market faster.

Life Sciences sessions

Us the below direct links to each session and add to your re:Invent schedule:

Life Sciences Industry: Executive Outlook – Tuesday, December 8th- 10:45 AM to 11:15 AM PST
Learn how AWS technology is helping organizations improve their data liquidity, achieve operational excellence, and enhance customer engagement. Speaker- Shez Partovi, Director Healthcare & Life Sciences- AWS

Improving data liquidity in Roche’s personalized healthcare platform -Tuesday, December 8th- 2:30 PM to 3:00 PM PST
Learn how Roche’s personalized healthcare platform is accelerating drug discovery and transforming the patient journey with digital technology. Speaker- Mustaqhusain Kazi, Head of Personalized Healthcare- Pharma Informatics – Roche

AstraZeneca genomics on AWS: from petabytes to new medicines – Wednesday, December 9th- 9:30 AM to 10:00 AM PST
Learn how AstraZeneca built an industry leading genomics pipeline on AWS to analyze 2 million genomes in support of precision medicine. Speaker- Slave Petrovski , VP and Head of Genome Analytics – AstraZeneca

Building patient-centric virtualized trials – Wednesday, December 9th- 2:45 PM to 3:15 PM PST
Learn how Evidation Health architects on AWS to create patient-centric experiences in decentralized and virtual clinical trials. Speaker- Alessio Signorini, Chief Technology Officer – Evidation Health

Streamlining manufacturing and supply chain at Novartis -Thursday, December 10th- 7:15 AM to 7:45 AM PST
Learn how Novartis is creating real-time analytics and transparency in the pharma manufacturing process and supply chain to bring innovative medicines to market. Speaker- Amit Nastik, VP Strategy & Operations and Local Markets Manufacturing – Novartis

Accelerating regulatory assessments in life sciences manufacturing-Thursday, December 10th- 1:45 PM to 2:15 PM PST
Learn how Merck leveraged Amazon Machine Learning to build an evaluation and recommendation engine for streamlining pharma manufacturing change requests. Speakers John Baker, Executive Director, ML & Analytics – Merck
and Kyle Hayes, Director Regulatory Affairs, CMC – Merck

Other related sessions of interest:

SAP transformation and GxP compliance at Bristol Myers Squibb

Transform research environments with Service Workbench on AWS

AWS Partners driving innovation amidst COVID-19

Securing Personal Health Information and High Risk Data Sets

Accelerating enterprise-wide AI/ML innovation

Life Sciences Attendee Guide

Download the full Life Sciences Attendee Guide below to get further information on industry sessions, activities, and “how to re:Invent.”

Kelli Jonakin, Ph.D.

Kelli Jonakin, Ph.D.

Kelli Jonakin is the Principal Marketing Manager for the Life Sciences and Genomics Industry verticals at AWS. She comes with a background in pharmaceutical research, with a special focus on development and commercialization of biologics. Kelli received her Ph.D. in Pharmacology and Systems Biology from the University of Colorado, and received an NIH post-doctoral fellowship grant to study Biochemistry at the University of Wisconsin-Madison.